A director at Bank Negara Indonesia (Persero) Tbk PT sold 4,300,000 shares at 4,208.195IDR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ...
Summary PT Bank Pan Indonesia Tbk - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights PT Bank Pan Indonesia Tbk (Panin Bank) is a provider of personal and business banking solutions. The bank offers savings and current accounts, debit and credit cards, mortgages, car and person...
Strategy: Sectors That Suffer Little Impact From Rising Commodity Prices: Our picks are: BBNI, BBTN, BMRI, BBYB, MAPI, LPPF, ERAA, KLBF and TLKM. Underweight: MYOR. TRADERS’ CORNER Bukalapak.com (BUKA IJ): Technical BUY Unilever Indonesia (UNVR IJ): Technical BUY
With commodity prices skyrocketing, coal and mining companies should benefit. To avoid the fluctuation of commodity prices, investors can establish positions in sectors that are minimally affected by rising commodity prices. The sectors are: a) banking & digital banks, b) healthcare and pharmaceutical, and c) telco & technology. We are Underweight on the consumer sector. Our picks are: BBNI, BBTN, BMRI, BBYB, MAPI, LPPF, ERAA, KLBF and TLKM. Underweight: MYOR.
BANK NEGARA INDONESIA (ID), a company active in the Money Center Banks industry, loses a star(s) at the fundamental level and sees its general evaluation downgraded. The independent financial analyst theScreener just removed a fundamental star(s) for a 3 over 4-star rating. As such, market behaviour remains unchanged and is evaluated as moderately risky. theScreener believes that the loss of a star(s) merits downgrade to the general evaluation of the title, which passes to Neutral. As of the ana...
GREATER CHINA Strategy Alpha Picks: March Conviction Calls: Though near-term risks remain, we expect the indices to continue their slow recovery as China enters a period of stimulus and easier policies. Add CATL, CSPC, Haitian, HKEX, Jiumaojiu, Tongcheng-Elong and ZTE to our BUY list. INDONESIA Strategy Alpha Picks: Stay Defensive When Uncertain: Our picks: UNVR, SIDO, BMRI, TLKM, KLBF, ROTI and BBNI. MALAYSIA Strategy Alpha Picks: Digging More Trenches: Feb 22 Alpha Picks underperformed the F...
The JCI rose 4% in Feb 22 and most of our stock picks failed to outperform. Our portfolio delivered a 1.6% return in Feb 22, underperforming the JCI. With the ongoing war between Russia and Ukraine, the market would be volatile in the short term and it would be wise to stay defensive. We are not changing our portfolio as it is quite defensive, consisting of pharmaceutical, consumer, telco and bank stocks. Our picks are UNVR, SIDO, BMRI, TLKM, KLBF, ROTI and BBNI.
GREATER CHINA Strategy Alpha Picks: February Conviction Calls: Though near-term risks remain, the indices are set to rebound as investor sentiments strengthen on better policy newsflow. Add JD.com and Xinyi Solar to our BUY list. INDONESIA Strategy Alpha Picks: Starting 2022 With Outperformance: Our picks: UNVR, SIDO, BMRI, TLKM, KLBF, ROTI, and BBNI. MALAYSIA Strategy Alpha Picks: Embracing The High Beta Picks: While our Jan 22 Alpha Picks underperformed, we expect good returns in February. F...
After underperforming in Dec 21, our portfolio outperformed in Jan 22. Despite JSMR’s 16.2% decline, our portfolio recorded a 0.7% rise vs the JCI’s 0.1% decline. Strong performances were recorded by BBNI, BMRI and SIDO. We would like to highlight KLBF and SIDO for the next one month as a higher number of COVID-19 infections could bode well for the demand for these companies’ products. Our picks are: UNVR, SIDO, BMRI, TLKM, KLBF, ROTI and BBNI.
GREATER CHINA Sector Automobile: Weekly: PV sales rebounded right before CNY, but may drop in January. Maintain OVERWEIGHT. Top picks: BYD, CATL, Ganfeng, Xusheng and Nexteer. Update Sihuan Pharmaceutical Holdings Group (460 HK/Not Rated): Becoming a leading player in medical aesthetics in China. INDONESIA Results Bank Negara Indonesia (BBNI IJ/BUY/Rp7,200/Target: Rp8,780): 4Q21: Higher than our and market expectations; NPAT to grow 35.7% yoy in 2022. MALAYSIA Results Pavilion REIT (PREIT MK/B...
BBNI’s 4Q21 NPAT rose 15.9% yoy to Rp3.15t, exceeding market expectations. Total COVID-19 restructured loans continued to improve at 12.4% of BBNI’s total loans in 2021, vs 18.6% in 2020. For 2022, we expect BBNI to report a loan growth of 8.6% yoy, in line with management’s guidance of 7.0-10.0%. NPAT could grow 35.7% yoy in 2022 (consensus: 39.1% yoy). Bank Mayora’s development into digital banking could create a new growth story. Maintain BUY with a higher target price of Rp8,780.
Omicron variant infections are rising across the globe and Indonesia has recorded 509 cases. Omicron is expected to peak in Feb 22 with new cases rising to as high as 60,000 cases daily. The impact of social restrictions could be milder. Healthcare (MIKA) and pharmaceutical (KLBF, SIDO) companies could see higher demand. A correction in the JCI should offer an opportunity to buy financial (BMRI, BBNI, BBTN), retail (MAPI, ERAA), consumer (UNVR, MYOR) and telecommunications (TLKM, EXCL) stocks.
Strategy: Beneficiaries Of Tax Amnesty: Infrastructure, healthcare and state-owned banks are the beneficiaries. Our picks: BMRI, BBNI, MIKA, KLBF, WIKA and PTPP. TRADERS’ CORNER PP London Sumatra Indonesia (LSIP IJ): Technical BUY Pabrik Kertas Tjiwi Kimia (TKIM IJ): Technical BUY
The second round of tax amnesty should benefit the 2022 state budget as the government will receive revenue from the tax amnesty. Higher state revenue would mean a potentially higher budget allocated for infrastructure, healthcare and education. Budgets for these three areas will remain high with a sharp rise seen for healthcare. State-owned banks could be the indirect beneficiaries in the form of higher loan growth. Our picks: BMRI, BBNI, MIKA, KLBF, WIKA and PTPP.
GREATER CHINA Strategy Alpha Picks: January Conviction Calls: We expect the indices to rebound in January on better policy news flow and improving investor sentiments. Add Venus MedTech, replace JD.com with Alibaba on our BUY list. INDONESIA Strategy Alpha Picks: Drop SMRA, ERAA and Add BBNI: Our picks: UNVR, SIDO, JSMR, BMRI, TLKM, KLBF, ROTI, EXCL and BBNI. MALAYSIA Strategy Alpha Picks: Embracing The High Beta Picks: Dec 21 alpha picks portfolio significantly outperformed the FBMKLCI, cappi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.